Dipeptidyl-peptidase IV can initiate the metabolism of GIP and GLP-1(7-36)amide in human serum [2]
the veins may also appear to be more prominent
Its a reasonable assumption
If MHRA approval arrives in late 2027 to mid-2028, private availability could begin from late 2027 or 2028, with NHS access from 2029
10.1111/jgh.15662 Summary Keywords glucagon-like peptide 1 receptor agonist, endoscopy, retained gastric contents, GLP-1RA, upper endoscopy, esophagogastroduodenoscopy (EGD) Citation Ukwade D, Hernandez LJ, Modi Z, Raza HS, Siegel M, Nwachukwu D, Sarraf P, Memon A, Booth M, Cooper K, Boulay BR and Mutlu EA (2025) GLP-1 receptor agonist increase retained gastric contents on EGD and same-day colonoscopy reduces this risk
Cons Its more expensive than some similar brands